Pyxis Oncology Correlations

PYXS Stock

USD 1.21 0.09 8.04%

The current 90-days correlation between Pyxis Oncology and Mereo BioPharma Group is 0.03 (i.e., Significant diversification). The correlation of Pyxis Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Pyxis Oncology Correlation With Market

Good diversification

The correlation between Pyxis Oncology and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pyxis Oncology and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pyxis Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.

Moving together with Pyxis Stock

0.78	EYEN	Eyenovia	Pair Corr
0.72	MOLN	Molecular Partners	Pair Corr
0.78	SNDL	SNDL Inc	Pair Corr
0.93	CLDX	Celldex Therapeutics	Pair Corr
0.75	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.66	CRVS	Corvus Pharmaceuticals	Pair Corr
0.63	ELMD	Electromed	Pair Corr
0.85	GKOS	Glaukos Corp	Pair Corr
0.73	ITGR	Integer Holdings Corp	Pair Corr
0.8	LIVN	LivaNova PLC	Pair Corr
0.65	MDAI	Spectral AI	Pair Corr
0.9	MODD	Modular Medical	Pair Corr
0.65	OTRK	Ontrak Inc	Pair Corr
0.86	APYX	Apyx Medical	Pair Corr
0.74	SGHT	Sight Sciences	Pair Corr
0.88	SRDX	SurModics	Pair Corr
0.89	CNMD	CONMED	Pair Corr

Moving against Pyxis Stock

0.86	CPIX	Cumberland Pharmaceuticals Downward Rally	Pair Corr
0.84	CMRX	Chimerix	Pair Corr
0.73	FNA	Paragon 28	Pair Corr
0.86	LUCD	Lucid Diagnostics	Pair Corr
0.81	NVRO	Nevro Corp	Pair Corr
0.74	INMD	InMode	Pair Corr
0.73	LUNG	Pulmonx Corp	Pair Corr
0.43	NYXH	Nyxoah	Pair Corr
0.9	BRK-A	Berkshire Hathaway	Pair Corr
0.9	BRK-B	Berkshire Hathaway	Pair Corr
0.75	NHNCF	NAVER Corp	Pair Corr
0.75	FWEDF	Fireweed Zinc	Pair Corr
0.63	PKX	POSCO Holdings	Pair Corr
0.6	TRGGF	Tarachi Gold Corp	Pair Corr

Related Correlations Analysis

	ZURA	EFTR	CYTO	ELEV	MREO	PDSB	XFOR	CRVS	TERN	ZVSA
ZURA		0.0	0.0	0.54	0.94	0.83	0.85	0.68	0.92	0.3	ZURA
EFTR	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	EFTR
CYTO	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	CYTO
ELEV	0.54	0.0	0.0		0.59	0.48	0.57	0.54	0.52	0.73	ELEV
MREO	0.94	0.0	0.0	0.59		0.81	0.86	0.73	0.9	0.32	MREO
PDSB	0.83	0.0	0.0	0.48	0.81		0.83	0.78	0.9	0.26	PDSB
XFOR	0.85	0.0	0.0	0.57	0.86	0.83		0.63	0.83	0.42	XFOR
CRVS	0.68	0.0	0.0	0.54	0.73	0.78	0.63		0.79	0.19	CRVS
TERN	0.92	0.0	0.0	0.52	0.9	0.9	0.83	0.79		0.29	TERN
ZVSA	0.3	0.0	0.0	0.73	0.32	0.26	0.42	0.19	0.29		ZVSA
	ZURA	EFTR	CYTO	ELEV	MREO	PDSB	XFOR	CRVS	TERN	ZVSA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MREO	+ 0.94	ZURA
TERN	+ 0.92	ZURA
TERN	+ 0.9	MREO
TERN	+ 0.9	PDSB
XFOR	+ 0.86	MREO
XFOR	+ 0.85	ZURA

High negative correlations

ZVSA	- 0.0	CYTO
TERN	- 0.0	CYTO
CRVS	- 0.0	CYTO
XFOR	- 0.0	CYTO
PDSB	- 0.0	CYTO
MREO	- 0.0	CYTO

Risk-Adjusted Indicators

There is a big difference between Pyxis Stock performing well and Pyxis Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pyxis Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
ZURA	4.83	(0.76)	0.54	9.79	(11.55)	29.06
EFTR	0.00	0.00	0.00	0.00	0.00	0.00
CYTO	0.00	0.00	0.00	0.00	0.00	0.00
ELEV	5.02	(0.86)	(0.65)	8.33	(9.43)	40.61
MREO	2.57	(0.46)	(0.68)	6.16	(6.13)	20.77
PDSB	4.57	(0.28)	(0.45)	9.21	(9.22)	33.91
XFOR	6.40	(0.54)	(1.69)	11.67	(13.51)	68.45
CRVS	4.12	(0.72)	(1.17)	7.37	(8.01)	43.50
TERN	2.99	(0.99)	(1.29)	4.94	(6.98)	19.13
ZVSA	4.57	(0.44)	(1.24)	12.03	(8.20)	38.26

Pyxis Oncology Corporate Management

Balu Balasubramanian	Interim Officer	Profile
Jan Pinkas	Chief Officer	Profile
Pamela MBA	Chief Officer	Profile
Charles Gombar	Senior Management	Profile
MBA MBA	CoFounder Chairman	Profile
MD FACP	Chief Officer	Profile
Jitendra Wadhane	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC